QI CAO | Health Professions | Best Researcher Award

Posted on by ScienceFather

Dr. QI CAO | Health Professions | Best Researcher Award

Doctor at West China Second University Hospital, China

Cao Qi is an Assistant Researcher at the prestigious West China Second Hospital, Sichuan University. With a robust academic background and significant research contributions, she has excelled in the fields of biological sciences, clinical medicine, and precision treatment models. Her research spans innovative projects funded by national and provincial bodies, focusing on polycystic ovary syndrome, premature ovarian failure, and nanomedicine. She has published 18 academic papers, including 8 SCI-indexed articles as a first or corresponding author, and has made meaningful contributions to systematic reviews, meta-analyses, and original research. Additionally, she has earned numerous academic honors and actively participates in peer-reviewing for renowned journals. Cao Qi is a promising researcher, combining innovative methodologies with multidisciplinary collaboration to make impactful contributions to the medical sciences.

Professional Profile

Education

Cao Qi pursued her undergraduate studies at the School of Life Sciences, Sichuan University, and Wu Yuzhang Honors College, where she majored in Biological Sciences and graduated as the top student in her class with a GPA of 3.84/4.00. She later enrolled in the Eight-Year Program of Clinical Medicine (Innovation Class) at West China School of Medicine, Sichuan University, achieving a GPA of 3.71/4.00 and ranking 7th among 86 students. This rigorous academic training equipped her with an interdisciplinary perspective and advanced expertise in biological sciences and clinical research, laying the foundation for her outstanding career as a researcher and clinician.

Professional Experience

Since July 2022, Cao Qi has served as an Assistant Researcher at West China Second Hospital, Sichuan University. In this capacity, she has contributed to cutting-edge medical research and innovation. Her responsibilities include leading and participating in high-impact projects on polycystic ovary syndrome, premature ovarian failure, and nanomedicine applications. Her work emphasizes the integration of scientific discovery with practical clinical solutions, further enhancing her institution’s reputation for excellence in medical research.

Research Interests

Cao Qi’s research interests focus on the precision treatment of endocrine and metabolic disorders, particularly polycystic ovary syndrome, premature ovarian failure, and related hormone metabolism disorders. She has explored the molecular mechanisms of nanomedicine activation by dietary antioxidants and their implications for granulosa cell function. Her work also encompasses innovative diagnostic and therapeutic strategies in reproductive health and endocrinology, including the use of transcriptional regulation in pregnancy loss and ovarian reserve decline.

Research Skills

Cao Qi possesses advanced research skills in molecular biology, clinical medicine, and translational research. Her expertise includes designing and conducting systematic reviews, meta-analyses, and clinical studies. She is adept at applying multidisciplinary approaches, such as nanotechnology and hormonal regulation, to address complex medical challenges. Her experience with grant writing and project management has enabled her to successfully lead national and provincial-level research projects. Additionally, her publication and peer-review work reflect her analytical proficiency and scientific rigor.

Awards and Honors

Cao Qi has received numerous accolades, including the First Prize in the Microbiology Application and Design Competition of Sichuan University and Wiley Press’ “Top Cited Article” and “Top Downloaded Article” distinctions for 2021-2022. She has been a peer reviewer for high-impact journals such as Diabetes Obesity & Metabolism and Chinese Medical Journal. She also received multiple scholarships, including the National Encouragement Scholarship and Sichuan University’s First-Class Comprehensive Scholarship, and was recognized as an Outstanding Graduate and West China Honors Graduate in 2022.

Conclusion

Cao Qi exemplifies the qualities of an exceptional researcher through her innovative contributions to medical science, outstanding academic record, and commitment to advancing healthcare. Her work in reproductive endocrinology and nanomedicine demonstrates her ability to address pressing medical challenges with precision and creativity. With her strong foundation in research, dedication to interdisciplinary collaboration, and recognition as a leading scholar, she is an ideal candidate for the Best Researcher Award.

Publication Top Notes

  1. Anesthetic anaphylactic shock in an emergency cesarean section: a case report
    • Authors: Qi Cao, Shengping Zhou, Hongqin Chen, Rong Zhou
    • Year: 2024
  2. Postpartum Glucose Follow-up Screening Among Women With Gestational Diabetes Mellitus: A Retrospective Cohort Study
    • Authors: Jiani Zhang, Tingting Xu, Qi Cao, Chihui Mao, Fan Zhou, Xiaodong Wang
    • Year: 2024
  3. Influencing factors of glycemic control in singleton pregnancies complicated by gestational diabetes mellitus in western China: A retrospective study
    • Authors: Jiani Zhang, Chihui Mao, Qi Cao, Guiqiong Huang, Xiaodong Wang
    • Year: 2024
  4. The association between testosterone and serum soluble klotho in females: evidence from the NHANES database
    • Authors: Qi Cao, Jiani Zhang, Xiaohu Hao, Siyu Du, Lu Ao, Huili Zhu, Wei Huang
    • Year: 2024
    • Citations: As of now, specific citation data for this article is not available.
  5. Testosterone does not mediate the correlation between dietary inflammation and serum klotho levels among males: insights from NHANES database
    • Authors: Siyu Du, Jieyi Zhao, Xinyue Chou, Jingyu Peng, Qi Cao, Yimiao Zeng, Lu Ao, Xiaoyu Wang
    • Year: 2024
  6. The Early Development of Offspring Born to Women with Polycystic Ovary Syndrome: Insights from a Prospective Birth Cohort Study in Southwestern China
    • Authors: Qi Cao, Ruiying Wang, Rong Zhou, Xin Huang, Yujing Li, Huili Zhu, Xinyu Qiao, Wei Huang
    • Year: 2024
  7. TfR associated with cervical cancer with or without neoadjuvant chemotherapy
    • Authors: Qi Cao
    • Year: 2023
  8. Development and validation of a fully automatic tissue delineation model for brain metastasis using a deep neural network
    • Authors: Jie-Yi Zhao, Qi Cao, Jing Chen, Wei Chen, Si-Yu Du, Jie Yu, Yi-Miao Zeng, Shu-Min Wang, Jing-Yu Peng, Chao You, et al.
    • Year: 2023
  9. Effect of vitamin D supplementation on hormones and menstrual cycle regularization in polycystic ovary syndrome women: A systematic review and meta-analysis
    • Authors: Yixian Han, Qi Cao, Xinyu Qiao, Wei Huang
    • Year: 2023
  10. The diagnostic value of glycosylated hemoglobin for gestational diabetes mellitus in Asian populations: A systematic review and meta-analysis
    • Authors: Jiani Zhang, Fan Zhou, Tingting Xu, Jinfeng Xu, Yaqian Li, Li Lin, Qi Cao, Xiaodong Wang
    • Year: 2022

 

 

Saeid Ferdousmakan | Health Professions | Best Researcher Award

Posted on by ScienceFather

Dr. Saeid Ferdousmakan | Health Professions | Best Researcher Award

Researcher at Nargund College of Pharmacy, Iran

Saied Ferdousmakan is a dedicated clinical pharmacist and researcher with a strong background in oncology, pharmacology, and medication safety. He earned his Doctor of Pharmacy (PharmD) degree from Rajiv Gandhi University of Health Sciences, Bengaluru, India, where he focused on medication safety in obstetrics and gynecology. His research interests are centered on miRNA-based therapeutic strategies for cancer, particularly liver cancer and melanoma, as well as autophagy mechanisms and immunotherapies. Saied’s expertise is further enhanced by practical experience as a clinical pharmacist, having worked in both India and Iran. He is committed to advancing cancer research and therapeutic interventions, actively contributing to scientific literature through publications and conference presentations. Saied is also engaged in continuous professional development, attending workshops on topics like molecular biology, immunoinformatics, and oncology. His soft skills in leadership, communication, and public speaking add to his overall capability as a researcher and healthcare professional.

Professional Profile

Education:

Saied Ferdousmakan holds a Doctor of Pharmacy (PharmD) degree from Rajiv Gandhi University of Health Sciences in Bengaluru, India, where he completed his studies from July 2013 to May 2019. His academic journey was marked by a focus on pharmacy, where he earned a GPA of 2870 out of 4500, recognized as a first division. His PharmD thesis, titled Medication Safety in Obstetrics and Gynecology Ward in Jayanagar General Hospital, Bangalore, highlighted his commitment to improving healthcare practices. His education laid the foundation for his ongoing research in therapeutic strategies and clinical pharmacy.

Professional Experience:

Saied’s professional career spans clinical pharmacy and research. From January 2023 to March 2024, he worked as a Clinical Pharmacist at Daryan Hospital in Iran, where he provided direct patient care and contributed to medication management. Prior to this, he completed an internship at Jayanagar General Hospital in India from July 2019 to July 2020. His role involved enhancing patient care and improving safety protocols in the hospital’s general medicine department. This clinical experience has strengthened his practical understanding of drug therapy, which complements his research focus.

Research Interests:

Saied Ferdousmakan’s primary research interests lie in the design and application of miRNA-based therapies for cancer, with a special focus on liver cancer. His work investigates miR-148a-3p as a negative regulator of glycometabolism and cell proliferation in liver cancer cells. Additionally, he explores the role of Ambra1 protein in autophagy, which contributes to drug resistance and cancer progression, particularly in melanoma. Saied is also involved in studying immunotherapies targeting CTLA-4 and PD-1 in melanoma, as well as developing inhibitors like PKC and C-Met for treating uveal melanoma. His interest extends to stem cell research and using NOV/CCN3 proteins to enhance hematopoietic stem cell function, particularly in cord blood units.

Research Skills:

Saied possesses strong research skills in molecular biology, immunotherapy, and pharmacology. His expertise in designing miRNA-based therapeutic strategies and his understanding of cancer biology, particularly in melanoma and liver cancer, reflect his solid foundation in experimental design. He is proficient in laboratory techniques such as PCR, cell culture, and Western blotting, which are crucial for his studies in autophagy and drug resistance. Additionally, Saied is skilled in statistical analysis and the use of bioinformatics tools like R for analyzing complex datasets. His involvement in international research conferences further attests to his ability to communicate complex scientific findings to diverse audiences.

Awards and Honors:

While specific awards and honors are not explicitly listed, Saied has made significant contributions to research and academia, as evidenced by his publications in reputable journals such as Cancer Cell International and Pak. J. Med. Health Sci., as well as his presentations at international conferences. His ongoing research in cancer treatment and medication safety has been well-received in academic circles. Additionally, his active participation in professional workshops and continuous learning showcases his commitment to personal and professional growth. These factors, combined with his practical work experience and leadership abilities, suggest that Saied is on track for future recognition in his field.

Conclusion

Saied Ferdousmakan presents a strong candidacy for the Best Researcher Award based on his impactful research focus in oncology, a solid record of publications and presentations, and practical experience in clinical settings. His commitment to continuous education through specialized workshops and his exceptional soft skills contribute positively to his profile. Expanding his technical expertise and range of published research would further enhance his credentials. Overall, Saied is a promising researcher with substantial potential to make meaningful contributions to pharmacology and oncology.

Publication Top Notes

  1. Current understanding of epigenetics role in melanoma treatment and resistance
    • Authors: M Karami Fath, A Azargoonjahromi, A Soofi, F Almasi, S Hosseinzadeh, …
    • Year: 2022
    • Citation Count: 35
    • Source: Cancer Cell International, 22(1), 313
  2. Reactive oxygen species induced by SARS-CoV-2 infection can induce EMT in solid tumors: potential role of COVID-19 in chemo-resistance and metastasis
    • Authors: M Moulaeian, S Ferdousmakan, S Banihashemi, S Homayounfar, …
    • Year: 2024
  3. Evaluation of pulmonary bacterial infections in people exposed to mustard gas
    • Authors: SM Fathi, Farzam Nasirzadeh, Zahra, Ferdousmakan, Saeid, …
    • Year: 2022
  4. Medication Safety in Obstetrics and Gynecology Ward in Jayanagar General Hospital, Bangalore, India
    • Authors: S Ferdousmakan, N KB, M Etesami
    • Year: 2021
    • Source: Pakistan Journal of Medical and Health Sciences, 15(5), 1270-1275
  5. Medication Safety in Obstetrics and Gynecology Ward in Tertiary Care Hospital, Bangalore, India
    • Authors: M Etesami, S Sirisha, S Ferdousmakan
    • Year: 2020
    • Source: Archives of Pharmacy Practice, 11(1-2020), 81-86
  6. Evaluation of Herpes Simplex Virus Types 1 and 2 in Patients with Multiple Sclerosis
    • Authors: SF Shahkamali, SMG Dazmiri, N Amirebrahimi
    • Year: Not specified